The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial

By Yu Zhaocai  

Supportive Care in Cancer, Vol. 17, Iss. 1, 2009-01 ,pp. : 99-102

Springer Publishing Company

Access to resources Recommend Favorite

Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies

By Roché Henri  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 755-765

Springer Publishing Company

Access to resources Recommend Favorite

Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer

By Murakami Michiyasu   Hashimoto Hiroki   Yamaguchi Kyohei   Yamaguchi Ikuko   Senba Shozo   Siraishi Takeshi  

Supportive Care in Cancer, Vol. 22, Iss. 4, 2014-04 ,pp. : 905-909

Springer Publishing Company

Access to resources Recommend Favorite

Hyperfractionated Radiation Therapy plus Chemotherapy in Locally Advanced Cervical Cancer: Results of Two Phase I Dose- Escalation Gynecologic Oncology Group Trials

By Calkins A.R.   Harrison C.R.   Fowler W.C.   Gallion H.   Mangan C.E.   Husseinzadeh N.   Alvarez R.D.   Mychalczak B.   Podczaski E.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 349-355

Elsevier

Access to resources Recommend Favorite

Analysis of aprepitant for prevention of chemotherapy-induced nausea and vomiting with moderately and highly emetogenic chemotherapy

By Molassiotis Alex   Nguyen Allison Martin   Rittenberg Cynthia N   Makalinao Alex   Carides Alexandra  

Future Oncology, Vol. 9, Iss. 10, 2013-10 ,pp. : 1443-1450

Future Medicine

Access to resources Recommend Favorite